Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 immunogenicity and safety study of MenACYW quadrivalent meningococcal conjugate vaccine in healthy Chinese children and adolescents
CTR20253146Phase 3Active
- Sponsor
- Sanofi Pasteur
- Start
- Sep 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal (groups A, C, Y, W) conjugate vaccine in meningococcal disease, sponsored by Sanofi Pasteur. Started Sep 2025; status: active.
02
Drugs
meningococcal (groups A, C, Y, W) conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on CTR20253146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253146.